Retrospective analysis identifies predictors of invasive candidiasis and mortality, highlighting machine learning potential for risk stratification.
Invasive candidiasis carries disproportionate mortality in hospitalised patients, yet the clinical determinants distinguishing invasive from non-invasive disease remain inconsistently characterised across healthcare settings. This study aimed to identify independent predictors of invasive candidiasis and in-hospital mortality, describe species distribution and antifungal resistance patterns, and evaluate machine learning models for risk stratification. A retrospective episode-level analysis was conducted on 206 laboratory-confirmed Candida -positive microbiological episodes at a single secondary care centre. Binary logistic regression univariable and multivariable was used to identify predictors of invasive candidiasis and all-cause mortality. Four machine learning classifiers (Random Forest, Gradient Boosting, Extra Trees, Logistic Regression) were developed and internally validated using five-fold stratified cross-validation. Permutation feature importance was applied for model explainability. Of 206 episodes, 37 (18.0%) were invasive. Overall, in-hospital mortality among invasive cases was 73.0%. Elderly age (≥ 65 years; aOR 53.22) and male sex (aOR 4.38) independently predicted invasive disease. Elderly age (aOR 5.12), male sex (aOR 4.96), and diabetes mellitus (aOR 2.60) were independent mortality predictors. Non-albicans species predominated among invasive isolates (73.0%), with Candida glabrata and Candida parapsilosis most over-represented. Fluconazole and caspofungin resistance were detected in 3/20 (15.0%) and 2/21 (9.5%) tested invasive isolates, respectively. The Random Forest classifier achieved AUROC values of 0.987 and 0.776 for invasive candidiasis and mortality prediction, respectively; the near-perfect invasive-candidiasis performance should be interpreted as exploratory and largely driven by marked age-based separation. Elderly age, male sex, and diabetes mellitus consistently predicted invasive disease and/or mortality in this episode-level cohort. Machine learning identified these routinely available variables as dominant discriminative features, but the models remain exploratory and require patient-level and external validation before clinical deployment.
No takes yet. Share an insight, caveat, or question.
Sannathimmappa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: